- Home
- ELTX vs CATX Comparison
ELTX vs CATX Comparison
Compare ELTX & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELTX | CATX |
|---|---|---|
| Founded | 2011 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.1M | 609.4M |
| IPO Year | 2014 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ELTX | CATX |
|---|---|---|
| Price | $11.85 | $5.19 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $15.00 | $11.89 |
| AVG Volume (30 Days) | 133.3K | ★ 1.5M |
| Earning Date | 01-01-0001 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.94 | 29.31 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,301,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.60 | $1.60 |
| 52 Week High | $14.93 | $6.16 |
Technical Indicators
Market Signals| Indicator | ELTX | CATX |
|---|---|---|
| Relative Strength Index (RSI) | 58.80 | 55.68 |
| Support Level | $7.78 | $3.24 |
| Resistance Level | $12.52 | $5.39 |
| Average True Range (ATR) | 1.12 | 0.39 |
| MACD | 0.05 | -0.10 |
| Stochastic Oscillator | 51.27 | 35.84 |
Price Performance
Historical ComparisonAbout ELTX Elicio Therapeutics Inc.
Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.